Pharma & Biotech

Eli Lilly, the pharmaceutical giant, has unsettled investors with a surprising move: the sudden termination of a mid-stage clinical trial...

Despite facing a recent FDA warning letter and significant stock sales by company executives, shares of telemedicine provider Hims &...

The biotechnology sector is watching closely as Liquidia Technologies, once a high-flyer following the celebrated launch of its flagship pulmonary...

Viking Therapeutics finds itself navigating complex challenges as it advances its obesity treatment portfolio. The company's oral drug candidate, VK2735,...

The oncology-focused biotechnology firm Ideaya Biosciences is demonstrating remarkable momentum in the markets. A combination of encouraging clinical trial results...

Iovance Biotherapeutics experienced a severe sell-off in the most recent trading session, with its shares plummeting 4.7 percent. The decline...

Inmune Bio's stock extended its decline in Friday's trading session, closing at $2.01 after a drop of 0.99%. The day's...

EssilorLuxottica (ESLX) experienced a significant boost this week, propelled by two major developments: a landmark regulatory approval for a groundbreaking...

The equity of Harvard Bioscience continues to experience a severe and prolonged decline. Despite the company's efforts to forge new...

The downward trajectory for Assembly Biosciences shares intensified during the latest trading session, marking a third consecutive day of declines....